Identification of biomarkers and pathways to identify novel therapeutic targets in Alzheimers disease: Insights from a systems biomedicine perspective
Md Rezanur Rahman, Tania Islam, Toyfiquz Zaman, Md. Shahjaman, Md. Rezaul Karim, Fazlul Huq, Julian M.W. Quinn, R. M. Damian Holsinger, Mohammad Ali Moni
This study identifies blood-based biomarker signatures and candidate drugs for Alzheimer's disease through integrative transcriptomics and network analyses.
bioRxiv · Apr 2, 2019 · PreprintSystems Biology